ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,208Medicare Part D Prescriptions Filled, Including Refills

Rank: 557 out of 2061

$819K Total Retail Price of All Prescriptions

Rank: 226 out of 2061

232 Patients Receiving at Least One Drug in Part D
20%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

69% of this provider’s 232 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

23% of this provider’s 232 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

4% of this provider’s 1,870 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$89 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
OXYCODONE HCL 822 174 S2 1 82
LISINOPRIL 305 70 2 2
PROAIR HFA 295 24 3 40
IBUPROFEN 285 31 4 90
CARISOPRODOL 280 18 R 5 156
GABAPENTIN 268 41 6 15
OXYCONTIN 255 50 S2 7 154
MORPHINE SULFATE ER 254 42 S2 8 166
ZOLPIDEM TARTRATE 246 41 9 23
OMEPRAZOLE 223 54 10 5
HYDROCODONE-ACETAMINOPHEN 219 45 S3 11 10
SIMVASTATIN 182 54 12 1
ENDOCET 159 12 S2 13 221
PROMETHAZINE HCL 148 16 R 14 119
FUROSEMIDE 147 56 15 6
CYCLOBENZAPRINE HCL 134 22 R 16 78
NEXIUM 133 24 17 26
AMLODIPINE BESYLATE 130 63 18 4
POTASSIUM CHLORIDE 123 42 19 16
CYMBALTA 119 30 20 59
SPIRIVA 118 13 21 63
ADVAIR DISKUS 107 0 22 57
TIZANIDINE HCL 86 17 23 137
ATENOLOL 84 24 24 13
TRAZODONE HCL 82 0 25 39
LEVOTHYROXINE SODIUM 82 29 25 3
AMOX TR-POTASSIUM CLAVULANATE 80 23 27 113
METFORMIN HCL 77 16 28 9
OXYCODONE-ACETAMINOPHEN 76 15 S2 29 36
HYDROCHLOROTHIAZIDE 76 11 29 12
ALPRAZOLAM 73 26 31 85
CITALOPRAM HBR 72 0 32 20
OPANA ER 70 22 S2 33 289
OXYCODONE HCL-ACETAMINOPHEN 64 22 S2 34 114
VENTOLIN HFA 62 0 35 234
PREDNISONE 59 12 36 32
METHADONE HCL 58 0 S2 37 198
KOMBIGLYZE XR 58 23 37 401
LYRICA 58 0 37 83
NAPROXEN 57 0 40 110
SUBOXONE 57 0 40 242
FLUOXETINE HCL 55 12 42 73
ATORVASTATIN CALCIUM 53 23 43 8
SYMBICORT 53 0 43 158
METOPROLOL TARTRATE 53 22 43 7
FENTANYL 52 0 S2 46 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.